BioNano Genomics has appointed Fahim Amini to serve as its new vice president of commercial operations for Europe, the Middle East, and Africa. In the role, he will be responsible for selling the company's Irys System into the EMEA markets.
Amini recently was director of EMEA at Complete Genomics, and before that, he played similar roles at Illumina and Affymetrix.
Nanosphere's shareholders have re-elected five members of its board of directors to continue serving until the next shareholder meeting in 2014, including: Sheli Rosenberg; Michael McGarrity; André de Bruin; Lorin Randall; and Michael Ward.